Modified quantitative and volumetric response evaluation criteria for patients with hepatocellular carcinoma after transarterial chemoembolization

Modified quantitative and volumetric response evaluation criteria for patients with hepatocellular carcinoma after transarterial chemoembolization

ObjectiveThis study aimed to investigate the cutoff value of quantitative and volumetric response evaluation criteria for patients with hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) and compare the performance of the modified criteria to one-dimensional criteria in surv...

Full description

Bibliographic Details
Main Authors:	Jiachen Xu, Yu Yin, Jun Yang, Li Chen, Zhi Li, Jian Shen, Wansheng Wang, Caifang Ni
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma transarterial chemoembolization tumor response European Association for Study of the Liver modified response evaluation criteria in solid tumors
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.957722/full

Similar Items

Radiomics features of computed tomography and magnetic resonance imaging for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis
by: Lijuan Feng, et al.
Published: (2023-07-01)

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
by: Al Fuhaid Turki, et al.
Published: (2007-01-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01)

Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
by: Zizhuo Wang, et al.
Published: (2024-08-01)

Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF score
by: Jia-Wei Zhong, et al.
Published: (2023-10-01)

Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study
by: Yuan H, et al.
Published: (2018-11-01)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
by: Won-Gyom Choe, et al.
Published: (2018-01-01)

Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma
by: Yang Y, et al.
Published: (2023-10-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
by: Yashwant Patidar, et al.
Published: (2021-04-01)

An Oxidative Stress-Related Prognostic Signature Predicts Treatment Response and Outcomes for Hepatocellular Carcinoma After Transarterial Chemoembolization
by: Ma H, et al.
Published: (2024-08-01)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
by: Lv WF, et al.
Published: (2018-10-01)

Transarterial chemoembolization in hepatocellular carcinoma treatment during the COVID-19 pandemic
by: Filipović Aleksandar, et al.
Published: (2024-01-01)

Laparoscopic closure of gastrohepatic fistula complicated by transarterial chemoembolization for hepatocellular carcinoma
by: Wei-Yi Liu, et al.
Published: (2024-10-01)

Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
by: Xie D, et al.
Published: (2024-04-01)

Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
by: Keisuke Koroki, et al.
Published: (2020-07-01)

Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases
by: Kamyar Ghabili, et al.
Published: (2024-11-01)

A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma
by: Hossein Ghanaati, et al.
Published: (2021-01-01)

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
by: Jiang JQ, et al.
Published: (2023-09-01)

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01)

Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
by: Farina M. Hanif, et al.
Published: (2014-10-01)

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
by: Zheng Y, et al.
Published: (2024-06-01)

Efficacy of Transarterial Chemoembolization (TACE) for Early-Stage Hepatocellular Carcinoma
by: Moonhyung Lee, et al.
Published: (2023-12-01)

Hepatogastric fistula formation after liver chemoembolization in a patient with hepatocellular carcinoma
by: S. A. Ivanov, et al.
Published: (2023-03-01)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01)

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
by: Rahmad Mulyadi, et al.
Published: (2024-05-01)

Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis
by: Ling Li, et al.
Published: (2022-02-01)

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
by: Hyun Young Woo, et al.
Published: (2015-12-01)

Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma
by: Ying Zhao, et al.
Published: (2023-10-01)

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
by: Xiu-Ping Zhang, et al.
Published: (2017-12-01)

Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
by: María L. Espejo-Cruz, et al.
Published: (2025-01-01)

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
by: Hao Li, et al.
Published: (2023-12-01)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
by: Fei-Xiang Wu, et al.
Published: (2017-09-01)

Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01)

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
by: Dominik Bettinger, et al.
Published: (2017-08-01)

Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy
by: Yue-Lin Zhang, et al.
Published: (2020-09-01)

Assessment of efficacy and safety of irreversible electroporation versus TACE for treatment of difficult location hepatocellular carcinoma
by: Mohamed Hassany, et al.
Published: (2024-05-01)

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
by: Huang Q, et al.
Published: (2020-09-01)

Prediction of hepatocellular carcinoma response to transarterial chemoembolization with intravoxel incoherent motion diffusion-weighted imaging
by: Abdolkarim Haji Ghadery, et al.
Published: (2022-05-01)

Sequential or simultaneous transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: A retrospective real‐world study
by: Jianwei Liu, et al.
Published: (2024-06-01)